Titan Pharmaceuticals, Inc.

TTNPNASDAQHealthcare

$2.34

$-0.30(-11.36%)

Market Cap$3112748

P/E Ratio—

52W High$15.15

52W Low$2.33

Avg Volume99K

Open$2.55

Beta1.38

Net Income Financials Revenue

Titan Pharmaceuticals, Inc. (TTNP) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TTNP · net income · updated Jun 9, 2026

Core profitability metrics

TTNP · net income · margin · TTM · CAGR

Net income was −$4.7M for FY2024 (fiscal year ending 2024-12-31), up 15.5% year-over-year. Net profit margin was —. Based on available data, Titan Pharmaceuticals, Inc. has been profitable since at least 2013.

FY2024 Net Income−$4.7M▲ +15.5% YoY

Trailing 12M (TTM)−$2.8Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+15.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · TTNP net income history · TTNP profit margin

Annual net income data

TTNP · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$4.7M▲ +15.5%—$0

FY2023Loss−$5.6M▲ +45.3%-556900.0%$1,000

FY2022Loss−$10.2M▼ 25.4%-16961.7%$60,000

FY2021Loss−$8.1M▲ +60.9%-531.7%$1.5M

FY2020Loss−$20.7M▼ 28.8%-428.4%$4.8M

Net income vs peers (Healthcare)

TTNP vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Titan Pharmaceuticals, Inc.YOU

TTNP

−$4.7M+15.5%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Titan Pharmaceuticals, Inc. (TTNP) reported net income of −$4.7M for FY2024 (fiscal year ending 2024-12-31), up 15.5% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Titan Pharmaceuticals, Inc. has been profitable since at least 2013. Net income reached a peak of $9.7M in FY2013. Data available for 15 fiscal years.

Titan Pharmaceuticals, Inc.'s net profit margin was — for FY2024, based on the latest annual results.

Investors sometimes search for "Titan Pharmaceuticals, Inc. net worth" — the company's market capitalization is a separate figure from TTNP net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TTNP net income · 4 questions

Titan Pharmaceuticals, Inc. is not currently profitable on an annual basis. The company reported a net loss of $4.7M for FY2024.

is TTNP profitabledoes TTNP make a profitTTNP profitabilityTTNP profitable company

▸ Source: FMP /income-statement · GAAP · Titan Pharmaceuticals, Inc. · Titan Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026